1. Speca M. A randomized, wait-list controlled clinical trial: the effect of a mindfulness-based stress reduction program on mood and symptoms of stress in cancer outpatients . Psychosom Med.2000;62: 613-622 .
3. Kabat-Zinn J. Effectiveness of a meditation-based stress reduction program in the treatment of anxiety disorders . Am J Psychiatry.1992;149: 936-943 .
4.
4. Miller JJ. Three-year follow-up and clinical implications of a mindfulness meditation-based stress reduction intervention in the treatment of anxiety disorders . Gen Hosp Psychiatry.1995;17: 192-200 .
5.
5. Williams KA. Evaluation of a wellness-based stress reduction intervention: a controlled trial . Am J Health Promotion.2001;15: 422-432 .
6.
6. Ernst E, Cassileth BR. The prevalence of complementary and alternative medicine in cancer: a systematic review . Cancer.1998;83: 777-782 .
7.
7. Adler SR, Fosket JR. Disclosing complementary and alternative medicine use in the medical encounter: a qualitative study in women with breast cancer . J Fam Pract.1999;48: 453-458 .
8.
8. Newell S, Sanson-Fisher RW. Australian oncologists' self-reported knowledge and attitudes about non-traditional therapies used by cancer patients . Med J Aust.2000;172: 110 .
9.
9. Gray RE, Greenberg M, Fitch M, et al. Perspectives of cancer survivors interested in unconventional therapies . J Psychosoc Oncol.1997;15: 149 .
10.
10. Frei E 3d, Kass F, JW. Dana-Farber Cancer Institute, Harvard Medical School Quality of life in cancer patients: clinical considerations and perspectives . Oncology.1990;4: 204-208 .
11.
11. Li C, Malone KE, Daling JR, Weiss NS. Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer . J Natl Cancer Inst.2001;93: 1008 .
12.
12. Clur A. Di-iodothyronine as part of the estradiol and catechol oestrogen receptor: the role of iodine, thyroid hormones and melatonin in the etiology of breast cancer . Med Hypotheses.1988;27: 303-311 .
13.
13. Morabia A, Szklo M, Stewart W, Schuman L, Thomas DB. Thyroid hormones and duration of ovulatory activity in the etiology of breast cancer . Cancer Epidemiol Biomarkers Prev.1992;1: 389-393 .
14.
14. Bunce IH, Mirolo BR, Hennessy JM, Ward LC, Jones LC. Post-mastectomy lymphoedema treatment and measurement . Med J Aust.1994;(161): 125-128 .
15.
15. Beinfield H, Korngold E. Chinese Medicine in Cancer Care. St Louis, Mo: Churchill Livingstone ; 2003.
16.
16. Wenjun Yu. Investigation into a new system for the treatment of cancer with Chinese medical substances . J Chin Med.1988;26: 29-46 .
17.
17. Halevi S. Can cancer be defeated by acupuncture? A case history analysis . J Chin Med.1988;26: 5-8 .
18.
18. He JP, Friedrich M, Ertan AK, et al. Pain-relief and movement improvement by acupuncture after ablation and axillary lymphadenectomy in patients with mammary cancer . Clin Exp Obstet Gynecol.1999;26: 81 .
19.
19. Zhang D, Zheng X, Wang Q. Clinical study on climacteric syndrome treated by acupuncture and moxibustion . Shanghai J Acupuncture Moxibustion.1999;3: 29-32 .
21. Hammar M, Frisk J, Grimas O, et al. Acupuncture treatment of vasomotor symptoms in men with prostatic carcinoma: a pilot study . J Urol.1999;161: 853 .
22.
22. Zhang D, Zheng X, Wang Q. Clinical study on climacteric syndrome treated by acupuncture and moxibustion . Shanghai J Acupuncture Moxibustion.1999;3: 29-32 .
23.
23. Deadman P, Al-Khafaii M. A brief discussion of the points of the Window of Heaven . J Chin Med.1993;43: 23-34 .
24.
24. Wu B, Zhou R, He J. Current situation and prospect of research on acupuncture mediating immunoresponse . Shanghai J Acupuncture Moxibustion.1999;1: 73-76 .
25.
25. Wei Z. Clinical observation on therapeutic effect of acupuncture at St 36 for leukopenia . J Tradit Chin Med.1998;18: 94-95 .
26.
26. Guorui T. The use of tonics in China—past, present, and future (monograph). Bejing: Academy of Traditional Chinese Medicine ; 1981.
27.
27. Newell CA, Anderson L, Phillipson J. Herbal Medicines: A Guide for Health-Care Professionals. London, UK: The Pharmaceutical Press ; 1996.
28.
28. Boik J. Natural Compounds in Cancer Therapy. Princeton, Minn: Oregon Medical Press ; 2001.
29.
29. Dharmananda S. The Interactions of Herbs and Drugs. Portland, Ore: Institute for Traditional Medicine ; 2001.
30.
30. Tagliaferri M, Cohen I, Tripathy D. Complementary and alternative medicine in early-stage breast cancer . Semin Oncol.2001;28: 121-134 .
31.
31. Bensky D, Gamble A. Chinese Herbal Medicine: Materia Medica. Seattle, Wash: Eastland Press ; 1986.
32.
32. Maciocia G. The Practice of Chinese Medicine. Edinburgh: Churchill Livingstone, Medical Division of Longman Group UK Limited Distributed in the United States of America by Churchill Livingstone ; 1994.
33.
33. Sun Y, Hersh EM, Lee SL, McLaughlin M, Loo TL, Mavligit G. Observations on the effects of the Chinese medicinal herbs Astragalus membranaceus and Ligustrum lucidum on lymphocyte blastogenic responses . J Biol Response Mod.1983;2: 227-237 .
34.
34. Lahmann PH, Lissner L, Gullberg B, Olsson H, Berglund G. A prospective study of adiposity and postmenopausal breast cancer risk: the Malmo Diet and Cancer Study . Int J Cancer.2003;103(2): 246-252 .
35.
35. Goodwin PJ, Ennis M, Pritchard KI, et al. Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study . J Clin Oncol.2002;20(1): 42-51 .
36.
36. Kaaks R, Lukanova A Energy balance and cancer: the role of insulin and insulin-like growth factor-I . Proc Nutr Soc.2001;60(1): 91-106 .
37.
37. Swaneck GE, Fishman J. Covalent binding of the endogenous estrogen 16 alpha-hydroxyestrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localization . Proc Natl Acad Sci U S A.1998;85: 7831-7835 .
38.
38. Telarg NT, Suto A, Wong GY, Osborne MP, Bradlow HL. Induction by estrogen metabolite 16 alpha-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells . J Natl Cancer Inst.1992;84: 634-638 .
39.
39. Meilahn EN, DeStavola B, Allen DS FI, Bradlow HL, Sepkovic DW, Kuller LH. Do urinary oestrogen metabolites predict breast cancer? Guernsey III cohort follow-up . Br J Cancer.1998;78: 1250-1255 .
40.
40. Michnovicz JJ, Bradlow HL. Induction of estradiol metabolism by dietary indole-3-carbinol in humans . J Natl Cancer Inst.1990;82(11): 947-949 .
41.
41. Michnovicz JJ, Adlercreutz H, Bradlow HL. Changes in levels of urinary estrogen metabolites after oral indole-3-carbinol treatment in humans . J Natl Canc Inst.1997;89(10): 718-723 .
42.
42. Musey PI, Collins DC, Bradlow HL, Gould KG, Preedy JR. Effect of diet on oxidation of 17 beta-estradiol in vivo . J Clin Endocrinol Metab.1987;65(4): 792-795 .
43.
43. Liebmann PM, Wölfler A, Felsner P, et al. Melatonin and the immune system . Int Arch Allergy Immunol.1997;112: 203 .
44.
44. Löffler M. Melatonin as antioxidant—use or misuse? Exp Clin Endocrinol Diabetes.1996;104: 308 .
45.
45. Panzer A, Viljoen M. The validity of melatonin as an oncostatic agent . J Pineal Res.1997;22: 184 .
46.
46. Jacobson JS, Workman SB, Kronenberg F. Research on complementary/alternative medicine for patients with breast cancer: a review of the biomedical literature . J Clin Oncol.2000;18: 668 .
47.
47. Lissoni P, Barni S, Ardizzoia A, et al. A randomized study with the pineal hormone melatonin versus supportive care alone in patients with brain metastases due to solid neoplasms . Cancer.1994;73: 699 .
48.
48. Araki R, Inoue S, Osborne MP, Telang NT. Chemoprevention of mammary preneoplasia: in vitro effects of a green tea polyphenol . Ann N Y Acad Sci.1995;768: 215-222 .
50. Lerner M. Choices in Healing: integrating the best of conventional and complementary approaches to cancer. Cambridge, Mass: MIT Press ; 1994.
51.
51. Kaplan P. The Practice of Physical Medicine. Spirngfield, Ill: Thomas ; 1984.
52.
52. Ironson G, Field T, Scafidi F, et al. Massage therapy is associated with enhancement of the immune system's cytotoxic capacity . Int J Neurosci.1996;84: 205-217 .
53.
53. Diego MA, Field T, Hernandez-Reif M, Shaw K, Friedman L, Ironson G. HIV adolescents show improved immune function following massage therapy . Int J Neurosci.2001;106: 35-45 .
